Zagreb, Croatia · Founded 2024 · Privately Held (backing)
Developer of novel anti-inflammatory drugs designed to address unmet needs in treating Spondyloarthritis. P 3 Therapeutics is based in Zagreb, Croatia and was founded in 2024. Its last reported valuation was $5.4 million in Apr 2025. It has raised $110,000.
Last reported valuation
$5.4M
Oct 2026
Priced at
—
Total raised
$110K
Last round
—
Cap table — not yet on record
P 3 Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of P 3 Therapeutics with a free account
·Watch P 3 Therapeutics: the Monday email on marks, rounds and moves
